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Abstract 
More than 50% of genes in species from Drosophila to human undergo alternative 
polyadenylation (APA). It has been shown that neuronal tissues are highly enriched for 
usage of transcripts with extended alternative 3’ untranslated regions, which are 
products of APA. Specific function of these longer 3’ UTR transcripts are largely 
unknown; however, because the 3’ UTR can regulate transcript stability, translational 
efficiency, and localization, it is plausible that 3’ UTR switching in nervous tissues may 
serve important biological functions. We chose to study the extended 3’ UTR of Dscam1 
as it is one of several axon guidance genes that express an extended 3’ UTR mRNA 
isoform. We created a Dscam1 extended 3’ UTR mutant using the relatively new 
CRISPR/CAS9 system. We show that the Dscam1 extended 3’ UTR loss of function 
mutants have severe deficiencies in locomotor activity and display an increased mortality 
rate. We have identified that in S2 cells the RNA binding protein ELAV promotes use of 
the extended 3’ UTR of Dscam1 and also show that ELAV is capable of binding at least 
two putative binding sites located on the 3’ UTR of Dscam1. Elucidating the important 
function of these extended 3’ UTRs will benefit not only our knowledge of axon 
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Chapter One: Introduction 
 
1. 1 Regulation of Gene Expression 
 A gene is a discrete segment of DNA that encodes the sequence of a 
polypeptide or functional RNA [1]. Given that nearly all mitotic cells of an organism are 
genetically identical, it is primarily through differential regulation of gene expression that 
functional and phenotypic differences arise between diverse tissue types [2, 3]. At the 
most fundamental level, gene expression can be described as transcription of DNA to 
RNA, followed by translation of RNA to protein [4]. Regulation of gene expression is 
essential for proper cellular function and collectively refers to any mechanism that 
influences expression levels or spatio-temporal expression patterns of gene products. 
Gene expression can be regulated by a wide variety of processes including: chromatin 
remodeling, histone modification, DNA methylation status, transcription factors, co/post-
transcriptional regulation of RNA, translation, and post-translational modifications. 
Together, these processes account for the majority of all eukaryotic gene expression. 
A typical eukaryotic protein coding gene consists of a 5’ untranslated region (5’ 
UTR), one or more exons, one or more introns, and a 3’ untranslated region (3’ UTR) [5].  
Once the precursor messenger RNA (pre-mRNA) is transcribed by RNA polymerase II 
(RNA Pol II), it must undergo co/post transcriptional modifications (5’ capping, splicing, 
and 3’ end processing) to generate the final mature transcript [6]. These modifications 
not only influence overall gene expression, but can also generate gene products (usually 
protein or non-coding RNA) with differing function [7]. 
 
1.2 Tissue-Specific Transcriptional Regulation Through Transcription Factors 
In human, there are more than 1,400 different sequence-specific transcription 
factors and many are expressed in a signal- or tissue-specific manner [8, 9]. This allows 
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for tightly controlled expression of genes in different tissues despite every cell type 
containing the same DNA cis-regulatory sequences.  
Transcription factors promote transcriptional activation upon binding their 
corresponding cis-regulatory sequences, which are located within promoter regions and 
enhancer elements of genes [10]. Unlike the promoter, which is often located just 
upstream of the genes coding region, enhancers can be located tens to hundreds of 
kilobases away from the gene they regulate; despite this, enhancers heavily influence 
transcriptional activation. This is because DNA is able to loop out extra sequence in 
order to bring the enhancer elements spatially close to the promoter. In contrast to 
enhancers, silencers are enhancer –like motifs capable of repressing transcription. 
  
1.3 The 3’ UTR: A Platform for Post-transcriptional Regulation 
 Aside from transcription factors, which are the primary determinates of gene 
activity, post transcriptional regulation allows attenuation of expression. Post-
transcriptional gene regulation refers to a collection of regulatory mechanisms that take 
place at the RNA level. In particular, the binding of microRNAs (miRNAs), and RNA 
binding proteins (RBPs) account for a large portion of post-transcriptional regulation. 
While both miRNAs and RBPs are able to bind many regions of a transcript, binding of 
these elements frequently occurs at the 3’ UTR.  
The 3’ UTR of a transcript is heavily enriched for regulatory sequence motifs and 
secondary structure that miRNA and RBPs recognize and act on [11, 12]. This 
enrichment of regulatory motifs is what makes the 3’ UTR a powerful regulatory element, 
able to influence transcript stability, localization, and translational efficiency [13-16]. The 
3’ UTR is found immediately downstream of the gene’s coding region. Its length, and 
therefore the motifs it contains, is determined after cleavage and polyadenylation occurs. 
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1.4 Post-transcriptional Regulatory Elements 
MicroRNAs are a pervasive class of short non-coding regulatory RNAs with more 
than 200 in fly and 1,000 validated in human [17, 18]. miRNAs are able to repress their 
target genes by binding to a specific target site complementary to the miRNAs seed 
region. While some miRNAs are ubiquitously expressed, many are able to silence genes 
in a tissue-specific manner. This can happen through transcript deadenylation, 
destabilization, and translational repression [19]. miRNA target sites are most often 
located within the 3’ UTR region of a mRNA transcript and a given transcript may be 
under the control of multiple miRNAs. Collectively, miRNAs are predicted to regulate 
expression of at least 50% genes in the human genome, if not more [20]. Several 
studies have shown some miRNAs to be critical for proper development in C. elegans, 
bovine, and zebrafish [21-23]. In contrast to this, another study deleted whole families of 
miRNAs in C. elegans with little effect, suggesting some miRNAs may be redundant or 
only important in the right biological context [24, 25]. Regardless, miRNAs fine tune gene 
expression in many organisms from fly to human [26, 27]. 
 RNA binding proteins (RBPs) are a large class of proteins capable of interacting 
with RNA to influence many aspects of a transcripts fate. Collectively, RBPs exhibit a 
plethora of functions by serving as localization signals, acting as scaffolds, tethers, 
nucleases, RNA editors, and binding competitors. RBPs are composed of modular 
recognition motifs and enzymatic domains separated by linker sequences. RBPs utilize 
these domains in a combinatorial fashion, giving rise to a plethora of RBPs with different 




1.5 Cleavage and Polyadenylation 
In eukaryotic organisms, most nascent mRNA must first undergo 5’ capping, 
splicing, and 3’ end processing before it is considered a mature mRNA [29, 30]. 3’ end 
processing is a concerted co-transcriptional event referred to as cleavage and 
polyadenylation, which consists of endonucleolytic cleavage of the transcript followed by 
the addition of a homopolymeric sequence of adenosines via poly(A) polymerase (PAP). 
The poly(A) tail, which in mammals has been shown to be roughly ~250 nucleotides in 
length, serves as a nuclear export signal, influences transcript stability, and affects 
translational efficiency [29, 31, 32].  
 Cleavage and polyadenylation in mammals is a relatively well understood 
process that is carried out by the cleavage and polyadenylation complex which is 
comprised of protein cleavage/polyadenylation specificity factor (CPSF), cleavage 
stimulation factor (CstF), symplekin, cleavage factor I (CFI), cleavage factor II (CFII), 
PAP, poly(A) binding protein (PABP) in addition to a myriad of other accessory proteins, 
some of which have yet to be identified (Figure 1) [33, 34]. Out of these, CPSF and CstF 
constitute the two most important proteins of the 3’ cleavage machinery, consisting of 6 
and 3 subunits, respectively [35]. Subunits of both CPSF and CstF are able to interact 
with the C terminal Domain (CTD) of the large subunit of RNA polymerase II (RNAP II) 
[36]. Together, CPSF, CstF, and the CTD of RNAP II act as the scaffold for the rest of 
the 3’ processing factors [37]. It is in this fashion that the cleavage machinery complex is 
able to processively scan the nascent mRNA in a co-transcriptional fashion for its target 
sequences.  
Specific constituents of the cleavage machinery complex recognize conserved 
sequence motifs located at the 3’ terminus of the pre-mRNA. The polyadenylation signal 
(PAS) is the most notable motif, consisting of a highly conserved hexameric sequence 
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A[A/U]UAAA, and although multiple sequence variants of the PAS exist, this is by far the 
most common PAS in mice and human [38, 39]. It was long thought that CPSF-160 (the 
largest subunit of CPSF) was the primary component in PAS recognition; however, new 
evidence has indicated that Wdr33 and CPSF-30 (two subunits of CPSF) may in fact 
have the highest affinity for the A(A/U)UAAA element according to recent PAR-CLIP 
assays [40, 41]. The PAS is generally located 11-23 nucleotides upstream of the 
cleavage site, often a CA dinucleotide, where the β-CASP domain of CPSF-73 will 
cleave the transcript [42-44].  
In addition to the PAS, mammalian pre-mRNAs have been shown to often, but 
not always, contain a downstream sequence element (DSE) as well as an upstream 
sequence element (USE) at the 3’ end of the transcript. These elements greatly enhance 
the activity of the cleavage and polyadenylation machinery [42]. The DSE consists of a 
U/GU-rich element within 30 nucleotides 3’ of the cleavage site that is recognized by 
CstF-64 (one of the three subunits that make up CstF) [45-47].  A typical USE consists 
of a UGUA or U-rich motif that is recognized and bound by CFI, which helps stabilize 
CPSF to the PAS [48]. The USE is especially important in cases where a canonical PAS 
is absent and recruitment of CPSF is solely dependent on CFI [49]. Collectively, the PAS 
with the USEs and DSEs define the poly(A) site of nascent mRNA and allow for 
specificity by the cleavage and polyadenylation complex. 
Upon CPSF, CstF, and CFI binding their appropriate sequence elements, the 
remainder of cleavage factors such as CFII and PAP that compose the cleavage 
machinery are recruited. The completed complex induces the CPSF-73 subunit to cleave 
the transcript [50]. At this point PAP begins polyadenylating the 3’ end and PABP binds 
the elongating poly(A) tail which promotes faster elongation by PAP [51]. When the 
poly(A) tail reaches between 250 and 300 nucleotides long elongation is terminated and 
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the cleavage and polyadenylation machinery becomes completely dissociated from the 
transcript, which is then exported to the cytoplasm [51]. 
 
1.6 Alternative cleavage and Polyadenylation 
 The most recent studies estimate that the human genome contains roughly 
19,000 protein coding genes [52]. Comparatively, the Mus musculus genome is 
estimated to encode slightly over 20,000 protein coding genes, while drosophila 
melanogaster encodes approximately 14,000, and C. elegans encode more than 19,000 
protein coding genes [53-55]. The differences in phenotypic complexity arisen between 
species cannot be explained by number of protein coding genes alone. It is now thought 
that differences in complexity arise from regulation via non-coding DNA as well as 
mechanisms including DNA methylation, histone modification, and co/post-
transcriptional modification [56-58].  
One form of co-transcriptional modification is alternative cleavage and 
polyadenylation (APA), which allows formation of gene transcripts with varying 3’ UTR 
lengths (Figure 2). 3’ UTR APA occurs when more than one polyadenylation site exists 
within the 3’ end of a particular gene. 3’ UTR APA is the most prevalent type of APA and 
generates transcripts that code for the same protein, while only changing the length of 
the 3’ UTR used [59].  Cleavage machinery can cleave at the more proximal 
polyadenylation site, generating a short 3’ UTR isoform of that gene, or at the more 
distal site, creating a long 3’ UTR isoform of that gene. As previously discussed, the 3’ 
UTR harbors many regulatory elements, and by altering the 3’ UTR being used, the 
repertoire of trans-acting elements changes, which can cause dramatic changes in 
regulation. 
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Messenger RNA transcripts with alternative 3’ UTRs were first discovered in 
1980, however, it was not until expressed sequence tag data analysis, and later the 
advent of RNA-Seq, that the extent of APA was revealed genome-wide [38, 60-64]. 
About 70% of human genes are subject to APA, while about 50% of genes in fly and 
worm have been observed to undergo APA [65-67].  
 
1.7 Mechanisms of APA  
There are several hypotheses regarding how a particular polyadenylation site is 
chosen. The proximal polyadenylation site of multi-UTR genes tend to be weaker than 
their more distal counterparts [68]. A weaker site generally means that the PAS in 
context of its USE and DSE does not exhibit as high of a binding affinity for the cleavage 
machinery. This finding is consistent with the observation that when the abundance of 
some cleavage factors, such as CstF64, are increased, a shift to the usage of the 
weaker, more proximal polyadenylation site occurs (the converse is also true) [69]. 
However this trend does not apply to all cleavage factors. It was found that an increase 
in CFI expression leads to usage of the more distal site [70]. 
It has also been shown that RNAP II kinetics can influence polyadenylation site 
choice [71]. In a C4 fly mutant where RNAP II elongation rate is nearly half, it was seen 
that the proximal polyadenylation site for the gene polo was used preferentially when 
compared to the wild-type fly [72]. Additionally, this study demonstrates relevance for 
physiological splice site choice since flies mutant for the extended 3’ UTR isoform of 
polo are lethal. 
Another proposed mechanism suggests that RBPs are able to bind nascent 
transcripts co-transcriptionally to either competitively inhibit cleavage factors from 
binding to a particular polyadenylation site. In fly, one example of this is seen with the 
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pan-neuronally expressed RBP embryonic lethal abnormal vision (ELAV) [73]. The 
binding of ELAV to the nascent transcript causes a shift toward the use of the longer 3’ 
UTR isoform of many genes. Similarly, other studies show that Sex-lethal (SXL), and 
PABPN1 also can competitively bind sequence motifs near the polyadenylation site to 
prevent cleavage at proximal sites [74, 75]. In contrast to this, RBPs such as cytoplasmic 
polyadenylation element binding protein 1 (CPEB1) and heterogeneous nuclear 
ribonucleoprotein H (hnRNP H1) have been shown to bind near the proximal 
polyadenylation site to recruit cleavage factors to preferentially generate short 3’ UTR 
isoforms of transcripts [76, 77]. 
There is no reason to believe that any one of these regulatory mechanisms is 
exclusive. The regulation of polyadenylation site choice may be under the control of 
several regulatory pathways concurrently. 
 
1.8 APA in different Tissues  
While the exact function of the extended 3’ UTR isoform of many genes is poorly 
understood, it does not appear to be stochastic [78]. Proliferative cells, as well as 
oncogenic cells, tend to express shorter 3’ UTR isoforms of genes in contrast to 
differentiated healthy cells [79, 80]. Intuitively, it is thought that shorter 3’ UTR variants 
promote higher expression of protein via escape of negative regulatory elements such 
as micro RNA target sites located within longer 3’ UTRs [80, 81]. However there are 
many positive regulatory elements that may be contained within the 3’ UTR as well and 
3’ UTR length has been shown to be weakly correlated with mRNA stability [82, 83]. 
Polyadenylation site choice among transcripts appears to be relatively conserved 
amongst tissue types, even between species [65, 66]. Tissue-specific APA of transcripts 
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allows ubiquitous expression of a gene, while maintaining the ability to tailor the final 
product to the tissue-type. 
 
1.9 Neural APA 
In Drosophila, it has been shown that there is an enrichment of extended 3’ UTR 
isoforms of genes being used in neural-tissues, consistent with studies in mammals[84-
86]. Additionally, 383 extended 3’ UTR transcript isoforms were found to be expressed 
exclusively in fly head [66]. This stands in contrast with 3’ UTR shortening events that 
appear to be enriched in proliferative tissues such as testis [66]. One hypothesis 
explaining this enrichment argues that a complex tissue, like neurons, may require 
additional regulation of gene expression. This regulation can in part be provided by 
transcripts with longer 3’ UTRs.  
Neurons are very polarized cells, some with axons that can be many times longer 
than the diameter of the cell body. Localizing transcripts before translation may be more 
energetically favorable than transporting the large amount of the protein. For example, 
one study shows that brain-derived neurotrophic factor (BDNF) is capable of undergoing 
APA to generate a long 3’ UTR isoform that localizes specifically to dendrites [87]. 
Similarly (RanBP1) was shown to have a long 3’ UTR variant that was able to promote 
axonal localization of a reporter construct [88].  
 
1.10 ELAV: A regulator of 3’ UTR extension 
 Embryonic lethal abnormal vision (ELAV) is a pan-neuronally expressed 
Drosophila RBP that has long been known to influence alternative splicing of genes such 
as neuroglian (nrg), erect wing (ewg), and armadillo (arm) [89, 90]. More recently than 
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this, it has also been found that ELAV is a regulator of APA in the central nervous 
system (CNS) [66, 73].  
ELAV is a nuclear localized protein first expressed around embryonic stage 11, when the 
Drosophila nervous system is forming [91]. It is known that ELAV and its human 
orthologs (HuB, HuC, HuD, and HuR) contain 3 RNA recognition motifs that bind U-rich 
sequences of mRNA transcripts [92-94].  
It has been suggested that ELAV binding U-rich elements within close proximity 
to the poly(A) site may block cleavage factors from binding there, causing RNAPII read-
through and cleavage to occur at the more distal site [73, 95]. A second hypothesis 
proposes that ELAV stabilizes extended transcripts by binding U-rich elements found 
throughout the UTR and without ELAV binding the transcript becomes unstable and is 
degraded [96]. 
 Elav mutants are embryonic lethal, but survive into early stages of neural 
development. One study showed that ELAV mutants exhibit severe axon guidance 
defects at the embryonic ventral nerve cord (VNC) [97]. Furthermore, the group shows 
that the Elav phenotype seen at the VNC is similar in manner to a comm full null mutant, 
a gene involved in axon guidance that expresses an extended 3’ UTR isoform. 
Interestingly, several genes involved in axon guidance including Dscam1, comm, and 
Fas1, express extended 3’ UTR isoforms. This led to the hypothesis that the extended 3’ 
UTR isoforms of these genes are necessary for proper embryonic neural development, 
and more specifically, axon guidance. 
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1.11 Axon Guidance  
 In the developing CNS of an organism, neurons project axons that must often 
traverse significant lengths to innervate their synaptic targets in a reliable manner [98]. 
The axonal growth cone is the fan-shaped axonal structure located at the tip of the 
elongating axon that is responsible for detecting and responding to extracellular 
guidance cues [99]. Guidance cues are primarily detected by receptors expressed at the 
cell-surface of the developing neuron and can either trigger an attractive or repulsive 
response [100].  Guidance molecules include adhesive glycoproteins that interact with 
the neuron as it navigates through its substrate, as well as diffusible ligands, which can 
be detected over long-distances. 
In chick embryonic retina, it was shown that adhesive molecules expressed in the 
extracellular matrix (ECM), such as the glycoprotein laminin, are required to direct 
developing axons toward their target [101]. In the zebrafish midbrain, it was further 
shown that laminins in the ECM are bound by integrin receptors located on the growth 
cone surface that direct the initial outgrowth of neurons [102]. In addition to laminin, 
transiently expressed axonal glycoproteins (TAGs) such as TAG-1 have been shown to 
be important for adhesion of axons to other developing axons [102, 103]. 
Apart from these “local” interactions, several secreted ligands have been 
identified which provide a concentration gradient for longer range signaling. This 
process, known as chemotropism, had long been postulated to be a guidance 
mechanism for developing neurons. The hypothesis was confirmed in an in vitro assay 
using rat spinal explants [104]. It was shown that commissural axons from the spinal 
explants would exhibit growth toward nearby floor-plate explants. At the time, the 
secreted factors were unknown, but since then, multiple guidance molecules have been 
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identified [98]. These include the netrins, slits, semaphorins, and ephrins, along with 
their respective receptors, DCC, Robo, the plexin receptors, and eph [105-108]. In 
recent years it has been shown that some these ligands, such as netrin and slit, can bind 
multiple receptors[109, 110]. 
 
1.12 Dscam1: The Down syndrome cell adhesion molecule 
The Drosophila Down syndrome cell adhesion molecule (Dscam1) is a 
transmembrane receptor that plays an important role in neurite self-avoidance, axon 
guidance, and maintenance of neural circuits [111]. While the gene itself belongs to the 
immunoglobulin superfamily, its role in immune function is less studied compared to its 
involvement in neural development. The gene name stems from the chromosome region 
in which the human homolog, DSCAM, is located. In human, the DSCAM locus is found 
in a region of chromosome 21 known as the “Down syndrome critical region,” a region 
containing a group of genes overexpressed in trisomy 21 [112].  
Dscam1 is the most extensively alternatively spliced gene known, capable of 
producing 304,128 unique transcript isoforms, and more than 38,000 different proteins, 
assuming every alternative splicing combination is possible [113, 114]. The primary 
source of this transcript diversity is attributed to alternative splicing of 3 hyper-variable 
exon clusters, 4, 6, and 9, containing 12, 48, and 33 alternative exons respectively. 
Additionally, exon 17 can be alternatively spliced, and exons 19 and 23 can be spliced 
out completely [114]. To further add to Dscam1’s transcript diversity, the Dscam1 gene 
is also capable of producing an extended 3’ UTR. While I suggest more than 300,000 
transcript isoforms are possible, determining how many exist in vivo is difficult due to 
read length limitations of traditional RNA-seq technology [115]. Using long-read 
sequencing with the MinIon nanopore sequencer, one group was able to confirm at least 
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7,874 unique splice-forms; however, this study only addressed splice patterns of the 
exon 4, 6, and 9 clusters, suggesting many more variants likely exist [113].  
The Dscam protein contains 10 immunoglobulin domains and 6 fibronectin type 
III domains. The exon 4,6, and 9 clusters are responsible for coding the immunoglobulin 
2, 3, and 7 domains [116]. These immunoglobulin domains are crucial for proper binding 
with other Dscam molecules and ligands; therefore, it is crucial proper splicing occurs for 
Dscam1 to maintain proper function (Figure 3). These three exons are each spliced in a 
mutually exclusive manner, ensuring that only one exon from each group is included in 
the mature transcript.  
Interestingly, multiple mechanisms may be working together to regulate 
mutualistic splicing in the exon 4, 6, and 9 exon clusters [117]. It was found that a highly 
conserved sequence motif (called the docking site) exists between the constant exon 5 
and the most proximal alternative exon 6 in 16 different Dipteran species, including 
Drosophila melanogaster. Moreover, the same study identified highly conserved 
sequences (termed the selector sequences) that resided in the introns between the 
alternative exons of the exon 6 cluster [118]. It is proposed that through complementary 
binding of the selector sequence to the docking site spatially arranges the pre-mRNA 
into an orientation that allows the spliceosome to include exactly one exon 6 variant into 
the final transcript. Ten years later, it was found that a similar mechanism is acting at the 
exon 4 and 9 variable regions [119]. Additionally, a RNA secondary structure (called the 
iStem) 18nt downstream of exon 3 was found to be necessary for exon 4 inclusion [120]. 
While both of these mechanisms explain how mutually exclusive splicing of Dscam1 
alternative exons might be regulated, it does not describe how specific exons are chosen 
to be included in the mature mRNA. 
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Dscam1 splice choice appears to be, at least in part, developmentally regulated. 
Although most alternative exons in the exons 4, 6, and 9 clusters were found to be 
expressed throughout development, a study using Dscam1 microarrays revealed a 
biased expression profile for certain exons at different developmental time-points [121]. 
The study also demonstrated that individual R3/R4 photoreceptor cells, and even 
individual S2 cells, each express between 14 and 50 variants of Dscam1. Furthermore, 
while individual cells express unique sets of Dscam1 splice variants, similar groups of 
tissues tend to express a unique repertoire of Dscam1 alternative exons [121]. Taken 
together, this suggests Dscam1 splicing is at least in part, a developmentally regulated 
process, and that expression of multiple Dscam isoforms confers neurons unique cell 
identity at the cell surface. The exact mechanism determining which Dscam1 isoforms 
are expressed in specific neurons remains unknown [122]. 
 Dscam1 induces contact-dependent repulsion of neurites through homophilic 
binding of the Dscam ectodomain, requiring the 3 variable immunoglobulin domains to 
be identical on both Dscam receptors [123]. Repulsion through homophilic-binding is 
responsible for correct morphogenesis of many types of neurons, and relies on 
neighboring neurons expressing unique sets of Dscam1 isoforms [122, 124].  
 Proper dendritic arborization of sensory neurons (dA neurons) in the larval body 
wall was found to be reliant on Dscam homophilic-binding [123]. Dscam1 loss of function 
mutants result in a collapse of the dendritic arbor and self-crossing of sister dendrites. In 
mice, DSCAM mutants show excessive branching and shortening of dendritic spines of 
pyramidal cells in the developing cortex [125]. 
 Dscam1 function is equally important for proper axon development as it is for 
dendritic arborization. Dscam1 is required for proper segregation of axons in the 
Drosophila mushroom body, a brain structure heavily implicated in olfaction and possibly 
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sensory integration [126, 127]. In the same study, it was also observed that individual 
neurons of the ellipsoid body that were limited to expressing a single isoform of Dscam1 
failed to properly arborize [126]. 
 To summarize, Dscam1 is critical for proper morphogenesis of both dendritic and 
axonal branches in several different neural tissues. Individual neurons express tens of 
Dscam1 splice variants which allow individual neurons to recognize sister branches, and 
the overall diversity of splice-forms possible allows one neuron to distinguish itself from 
other neurons. One study looked to investigate how much diversity is required for self-
avoidance and neural identity mechanisms to occur [128]. Strikingly, they also found that 
in order to get proper mushroom body formation, which requires thousands of neurons to 
bifurcate at a specific developmental time-point, between 1,100 and 4,800 isoforms are 
required. This data suggests that different tissue types require different amount of 
Dscam1 diversity to maintain proper function, but it does not directly address if specific 
isoforms play unique roles in certain tissues. 
In the same study, it was confirmed that expression of a single Dscam1 isoform 
was sufficient to rescue dendritic collapse of body-wall neurons that normally do not 
overlap; however, expression of single isoform Dscam1 caused ectopic repulsion of 
class I and III neurons which normally display overlapping fields of dendrites. Using 
Dscam1 mutant flies that allow expression of different amounts of Dscam1 isoforms 
(between ten and thousands), they found that somewhere between 12 and 24 Dscam1 
isoforms was sufficient to rescue both phenotypes to be indistinguishable from wild type 
in the body wall. 
 Interestingly, mammalian DSCAM and DSCAML1 are not alternatively spliced, 
nor are they alternatively polyadenylated, although function in neural development 
appears to be conserved [117]. Although DCC (Fra in fly) is thought to be the primary 
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receptor for Netrin-1, it was found that DCC likely acts in complex with DSCAM and 
binding of Netrin induces an overall attractive growth queue. Interestingly, while at least 
7 of the most N-terminal immune-globulin domains are required for homophilic binding 
(Igs 1-7), immunoglubulins 7-9 (only one of which being variable) are sufficient for Netrin 
binding, suggesting splice diversity might be less important for Netrin-1 binding [129, 
130].  
Aside from self-avoidance and neurite segregation, Dscam also functions in axon 
guidance as a receptor for the ligand Netrin-1 in the mammalian spinal cord [130]. More 
recently, Dscam1 was also found to be capable of binding Slit, a ligand known to bind 
the receptor Robo1 causing a repulsive signal [107, 110]. Normally, Slit binds Robo1, 
generating a repulsive queue preventing midline crossing and counteracting the 
attractive effects of Netrin/DCC binding [107]. In this new model, the N-terminal fragment 
of Slit was determined to bind the first 3 immunoglobulins of Dscam1, allowing Dscam to 
form a complex with Robo1 to prevent repulsive signaling in longitudinal axons of the 
midline [110]. Robo1 is predominantly expressed in longitudinal axons of the CNS 
midline, providing further evidence that Dscam1 performs varying functions in a tissue-
specific and developmentally relevant context [107]. 
 While I outline many functions of Dscam1 in neuron morphology and axon 
guidance, the function of the extended 3’ UTR isoform of Dscam1 remains unknown. 
One study showed that Drosophila fragile xXmental retardation protein (dFMRP) and 
Wallenda (Wnd) to two RBPs, act on Dscam1 to down-regulate protein expression [131]. 
It was found that Dscam expression is a regulator of the presynaptic arbor size in 
sensory neurons and mutants in either of these RBPs increased Dscam expression 
levels, resulting in increased arbor size. Only Wnd was found to bind the 3’ UTR of 
Dscam1, and the extended 3’ UTR was not examined. Characterization of the extended 
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3’ UTR and its motifs may help elucidate further how Dscam1 is regulated and how it 
carries out its various functions. 
 
1.13 CRISPR/CAS9: A non-disruptive approach to studying extended 3’ UTR 
function 
 Most genome editing techniques rely on double-stranded cleavage of the target 
DNA followed by repair of the break. Two endogenous cellular repair pathways exist, 
non-homologous end joining (NHEJ), and homology directed repair (HDR).  
NHEJ is the most commonly employed repair mechanism by the cell. First, a 
NHEJ protein complex recognizes the break and recruits other proteins required for 
repair. Usually the cut produces either blunt or incompatible overhangs. If overhangs 
exist, they are resected before DNA polymerases are able to incorporate new dNTPs. 
Lastly, DNA ligase IV is able to join the two ends. NHEJ results in random insertions or 
deletions (indels), which often cause frameshifts [132]. 
HDR is very useful because this repair pathway can be manipulated to cause 
implementation of exogenous DNA at the cleavage site [133]. HDR is able to occur when 
a donor template whose ends are homologous (homology arms) to the ends of the 
cleaved DNA, which is usually a double-stranded break, is present (DSB) [134].  By 
introducing exogenous DNA templates with homology arms to into cells that contain 
DSB in DNA, it is possible to insert entirely new portions of DNA into the genome [135]. 
Tools to specifically induce double-stranded breaks have been around since the 
1990’s after the advent of zinc finger nucleases (ZFNs) [136]. A zinc finger is a 30 amino 
acid long protein that is able to recognize a specific trinucleotide sequence. Different 
zinc fingers have been developed to recognize every different trinucleotide sequence 
possible and they are modular in fashion. Therefore, multiple zinc fingers are able to be 
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linked together via a zinc ion. Most importantly, an endonuclease domain (usually FokI) 
is then fused to the most 3’ zinc finger which allows cutting at a specific genomic site 
when directed by the zinc fingers. Collectively, the zinc fingers with the endonuclease 
domain are known as ZFNs. In order to cause a DSB, the FokI domains must dimerize.  
Therefore, ZFNs are used in pairs; one directed against the positive strand upstream of 
the cut site, and the other against the negative strand downstream of the cut site. Once 
cleavage has occurred, the site may be repaired via NHEJ or HDR.  
 The next major breakthrough in genome-editing technology arose through the 
discovery and application of transcription activator-like effector nucleases (TALENS) 
[137]. Transcription activator-like effectors (TALEs) are a large family of secreted DNA-
binding proteins, first discovered in Xanthomonas, which are able to bind DNA with 
single nucleotide specificity [138, 139]. Similarly to ZFNs, TALEs are able to be chained 
together modularly, and are fused to a non-specific nuclease domain, which when 
dimerized, is able to induce a double-stranded break at a specific locus. TALEs allow a 
greater flexibility in targeting due to the fact that each unit has single nucleotide 
specificity as compared to ZFN’s trinucleotide recognition, however, due to the highly 
repetitive nature of TALEs, they are costly to manufacture [140]. 
 The clustered regulatory interspaced short palindromic repeats (CRISPR) system 
is a new revolutionary genome editing technology that allows genome editing in a faster, 
cheaper, and more precise manner than that of ZFNs or TALENs. The CRISPR system 
was first identified as part of the adaptive immune system of bacteria [141].  
The endogenous system can be described in three parts: Foreign DNA 
integration, CRISPR RNA expression, and target cleavage. Following viral infection, a 
bacterium such as S. pyogenes, is able to retain and integrate fragments of viral DNA 
into a specific CRISPR locus within its own genome. Next, these integrated fragments 
19 
are expressed and processed into mature CRISPR-derived RNAs (crRNAs) [142]. In the 
endogenous system, a transactivating RNA (tracrRNA) hybridizes the crRNA through 
partial complementarity and acts as a scaffold to bind a non-specific CRISPR-associated 
endonuclease (Cas), most commonly Cas9. The 5’ end of the crRNA contains what is 
known as a protospacer element which is the sequence that confers specificity of Cas9 
to the target DNA. For the purpose of simplifying the system for genome editing, the 
crRNA and tracrRNA are combined into a single construct called guideRNA (gRNA). In 
addition to containing the protospacer sequence, which gives target specificity, the target 
DNA must also contain the protospacer adjacent motif (PAM), which is recognized by 
the Cas9 protein. Upon target recognition and binding a double stranded break is 
induced by the endonucleolytic activity of Cas9.  
 The CRISPR/Cas9 system has been shown to work in many model organisms 
including HEK293T cells, zebrafish, mouse, fly, worm, rat, frog, as well as Arabidopsis 
[143]. Conveniently, all components required for the CRISPR/Cas9 system can be 
expressed via microinjection of a single vector. Like both ZFNs and TALENs, CRISPR 
double-stranded breaks can be repaired via NHEJ or HDR by co-expressing a DNA 
fragment with sequence homology around the cleaved site. Due to Cas9 being an RNA-
guided nuclease opposed to a DNA-guided nuclease, it can easily be retargeted by 
simply changing the 20 nucleotide sequence of the gRNA, and therefore, no protein 
redesigning is necessary. Additionally, multiple regions can be targeted simultaneously 
by simply expressing multiple gRNAs. With these benefits in addition to its cost 
effectiveness, CRISPR/Cas9 has become the preferred genome editing tool of 
scientists.  
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Chapter Two: Materials and Methods 
Primers Synthesis: 
All primers and RNA probes were synthesized and obtained from Integrated DNA 
Technologies (IDT). All sequences are listed in appendix A. 
 
Genome browser analysis:  
The Integrative Genomics Viewer (The Broad Institute) was used for primer design 
validation, RNA-seq data analysis, and identification of Poly(A) sites along with their 
associated motifs. 
 
S2 Cell Transfection: 
Schneider 2 cells were obtained from Drosophila Genomics Resource Center (DGRC). 
Cells were cultured in Schneider’s Drosophila medium (ThermoFisher CAT# 21720024), 
with the addition of 10% fetal bovine serum (Atlanta Biologicals CAT# S11150). Cells 
were 80% confluent the day of transfection in a T25 tissue culture flask (USA Scientific 
CAT# CC7682-4825). The flask was then brought up to 15ml with fresh media, and 2ml 
aliquots were transferred to 6-well plates (USA Scientific CAT# CC7682-7506). Two 
hours were allowed to elapse to allow cells to become semi-adherent. All transfections 
were performed using the Effectene transfection reagent (Qiagen CAT# 301425) 
according to the manufacturer’s protocol for suspension cells. For co-transfections, 
500ng of the driver (tubulin-gal4) and 500ng of UAS-ELAV and/or reporter was added, 
for a maximum of 1.5ug being transfected if three plasmids were being introduced. Cells 
were collected 48 hours post-transfection and pelleted in preparation for RNA extraction. 
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RNA Extraction: RNA extracted from cell culture and Drosophila was performed using 
TRIzol reagent (Invitrogen CAT# 15596026) following the manufacturer’s protocol. 
Following extraction, and prior to cDNA synthesis, RNA was DNase treated using the 
DNA-free DNase Treatment and Removal Reagents (Ambion CAT# 1906) following the 
manufacture’s “Routine DNase treatment” protocol with 7ug of input RNA. 
 
Dscam1 3’ UTR Cloning: The Dscam1 3’ UTR was amplified from cDNA isolated from 
W1118 Drosophila melanogaster using iProof High-fidelity PCR kit (Bio-Rad 
Cat#1725330) per the manufacturer’s protocol (Primers used found in appendix).  All 
products were sub-cloned into Topo TA vector (Invitrogen CAT# K4575J10) per the 
manufacturer’s protocol for Sanger sequencing prior to cloning into the terminal vector. 
The Topo-insert vector was grown up in TOP10 cells included with the kit using the 
supplied protocol. Resultant colonies were inoculated into 25ml of LB broth (Fisher 
Scientific CAT#BP1426-500), left to grow overnight, and were midi prepped (Qiagen 
CAT# 12945) the next day. After sequence confirmation, the insert, and terminal vector 
were digested with the appropriate restriction enzymes (found in appendix, obtained 
from New England Biolabs), and run in a 1% agarose gel for 45 minutes at 120v. The 
digested insert and vector were recovered from the gel using a gel extraction kit (Qiagen 
CAT# 28704). The prepared vector and insert were then ligated together using T7 DNA 
ligase (New England BioLabs CAT# M0318) in a molar ratio of 1:3 vector to insert using 
the manufacturer’s protocol. The ligated vector was then grown in Top10 cells and midi 
prepped as described earlier. 
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Site-directed Mutagenesis: Mutagenesis of the putative proximal and distal ELAV 
binding sites was performed using the QuikChange II XL site-directed mutagenesis kit 
(Agilent CAT#200521) using the manufacturer’s protocol. The mutagenic primers were 
designed using Agilent’s primer design program (Primer sequence found in the 
appendix). 
 
CRISPR/CAS9 Deletion: The CRISPR/CAS9 deletion was performed by Well Genetics. 
Two gRNAs were designed flanking the extended 3’ UTR of Dscam1 which caused 
double-stranded breaks at positions chr2R: 3,204,852 and chr2R: 3,206926 generating a 
nearly 2kb deletion. A 134 bp region between the proximal Dscam1 short 3’ UTR 
cleavage site and the first double-stranded break was left in tact in order to not disturb 
any potential DSEs important to proper cleavage and polyadenylation of the short 3’ 
UTR isoform. HDR was used to knock-in a 1.8kbp RFP cassette containing loxP sites. 
RFP was used as a visible marker for screening successful mutants. Three successful 
Dscam1 dUTR mutants were generated with the expected deletion and knock-in. Flies 
were balanced over CyO or GFP CyO to create stable stocks. 
 
Genomic DNA extraction and Sanger sequencing: Genomic DNA extraction was 
performed using the DNeasy Blood and Tissue kit (Qiagen CAT#69504) per the 
manufacturer’s protocol. Endpoint PCR amplification (as described above) was carried 
out using the Dscam_deletion_Seq1&2 primers, which flank the deletion locus (Appendix 
II). 500ng of cDNA and 1ul of a 10uM sequencing primer was used as input for Sanger 
sequencing. Both ends of the deletion locus were sequenced for all three Dscam1 dUTR 
fly lines. Sanger sequencing was performed by the Nevada Genomics center using the 
3730 DNA Analyser (Applied Biosystems Model# 3730).  
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cDNA Preparation and qRT-PCR: Dnase treated RNA was reverse transcribed into 
cDNA using iScript Reverse Transcription Supermix for RT-qPCR (Bio-Rad CAT# 
1708840) as per manufacturer’s protocol using 1ug of RNA as input. cDNA was then 
diluted 1:5 in ddH2O. qPCR reactions were set up in clear low-profile 0.2ml 8-tube strips 
(Bio-Rad CAT# TLS0801) with 0.2ml flat PCR optical caps (Bio-Rad CAT# TCS0803). A 
diluted master mix was made with the ratio of of 10ul SYBR Green PCR Master Mix 
(Invitrogen CAT# 4309155) to 6.5ul ddH2O per reaction was first made. Next, a master 
mix for each pair of primers being tested was made using .75ul of each individual primer 
(at 10um) per reaction. Each individual reaction consisted of 16.5ul diluted master mix, 
1.5ul primer mix, and 2ul of 1:5 diluted cDNA. Thermocycling took place in a CFX96 
Touch Real-Time PCR Detection System (Bio-Rad CAT#1855195). All data was 
analyzed on Bio-Rad’s CFX software. 
 
Longevity Assay: Male flies were collected within 8 hours of eclosion and separated 
into groups of 10 by genotype using minimal CO2. Flies were transferred to vials with 
standard food and were kept at 25 degrees Celsius, 55% relative humidity, and a 12 
hour light-dark cycle. Flies were checked every two to three days for deaths and 
survivors flipped to fresh vials containing new food. Every group of 10 flies constituted 
an N=1. Data was plotted using excel. 
ELAV Protein Vector Creation, Expression, and Purification
Vector Creation: The coding region of ELAV was PCR amplified from cDNA isolated 
from w1118 Drosophila using AccuPrime Pfx DNA polymerase (Invitrogen CAT# 
12344024) per the manufacturer’s protocol. The product was then cloned into the 
pENTR/D-TOPO vector (Invitrogen CAT# K240020) donor vector per the manufacturer’s 
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protocol. The ELAV-pENTR vector was then grown up in One Shot TOP10 cells 
(Invitrogen CAT#C404003) per the manufacturer’s protocol. The destination vector 
chosen was pET-60-DEST (Novagen CAT# 71851-3) because it contained both a C-
terminal GST tag as well as a N-terminal 6xHis Tag. The destination vector was grown 
up in One Shot ccdB Survival 2T1R cells (Invitrogen CAT# A10460). Both vectors were 
then prepared using midi-prep (Qiagen CAT# 12945). The final expression vector was 
made using LR Clonase II (Invitrogen CAT#11791-020) enzyme per the manufacturer’s 
protocol, which flipped the ELAV coding region into the pDEST60 vector with the N and 
C-terminal tags. 
 
Protein Expression and Purification: BL21(DE3) Competent E. coli (New England 
Biolabs CAT# C2527l) were transformed with pDEST60-ELAV construct according to the 
manufacturer’s protocol. Cells were collected by centrifugation in 50ml centrifuge tubes 
(USA Scientific CAT# 1500-1811) for 15 minutes at 3000rpm. Cells were then 
suspended in 5ml of water and centrifuged again to rinse off leftover media. The water 
was decanted off and the cell pellet was resuspended in 30ml of a buffer containing 
25mM Tris HCl pH 7.5, 150mM NaCl, 20mM imidazole and 10mM MgCl2 with the 
addition of a protease inhibitor tablet (Thermo Scientific CAT#88666) and 30mg of 
lysozyme (Sigma CAT# L6876). The mixture was left to incubate for 30 minutes at room 
temperature. The cells were then sonicated (Branson Sonicator 450) on ice six times for 
15 second intervals at a power level of four. The sample was then centrifuged at 
28,000rpm for 1 hour at 4°C. 20ul of supernatant was collected to be later ran on a gel 
for quality analysis. Following sonification, 900ml of a buffer containing 25mM Tris HCl 
pH 7.5, 150mM NaCl, 20mM imidazole and 10mM MgCl2  and 290ul of 2-
mercaptoethanol was prepared. 2ml of glutathione agarose (Thermofisher CAT# 16100) 
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was then mixed with 48ml of the buffer just prepared, and was allowed to sit so the 
beads settled. Supernatent was then removed leaving only the beads at the bottom of 
the tube. The supernatant from the 1-hour centrifugation step was then added to the 
beads and incubated for 2 hours at 4°C with rocking. The rest of the purification took 
place at 4°C in a cold room. A chromatography column (Bio-Rad CAT# 7374021) was 
rinsed with the imidazole buffer containing the 2-mercaptoethanol, and all 50ml of the 
supernatant-glutathione bead mix was added to the column, allowing the beads to 
compact in the column. Some of the flow-through was kept for quality analysis 
performed later; the rest of the flow-through was discarded. To remove any material not 
bound to the agarose beads, 150ml of the buffer containing 2-mercapoethanol was 
added to the column to wash the beads, and the flow-through was discarded. To remove 
the ELAV bound protein, 0.28g of reduced L-glutathione (Sigma CAT# G4251) was 
added to 30ml of the buffer containing 2-mercaptoethanol. 10 ml of the reduced L-
glutathione solution was added to the column and left to incubate for 5 minutes. 
Following incubation, 8x1ml aliquots were collected. To determine which fraction 
contained the highest concentration of ELAV, 5ul from each fraction (and also the flow-
through samples collected) was aliquoted and added to new tubes each containing 5ul 
of SDS loading buffer. The samples were heated at 95°C for five minutes and then all 
samples were ran in a tris glycine gel for 30 minutes. The gel was then stained for 30 
minutes while shaking in a solution containing 3.75ml of acetic acid, 46.25ml of ddH2O 
and 10ul of sypro orange (ThermoFisher CAT# S6650). The gel was then scanned on a 
gel imager (GE Healthcare Typhoon Trio) to determine which fraction contained the 
most protein. That fraction with the most protein was then quantified using a BSA 
standard curve protocol, using ImageJ to quantify pixel intensity of the Flamingo-
stained(Bio-Rad CAT#161-0490) TrisGlycine Gel.  
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Electrophoretic Mobility Shift Assay 
Polyacrylamide Gel purification of Probes: All RNA oligos were ordered from 
Integrated DNA Technologies (Appendix II). The lipholized RNA was rehydrated to a 
concentration of 1nmol/ul. The oligos were then purified using a 12-15% denaturing 
polyacrylamide gel (ex. 15%: 14.2ml DEPC treated water, 48g Urea, 37.5 ml of 40% 
19:1 acryl:bis, 500ul 10%APS, 50ul Temed).  Denaturing gels were left to polymerize for 
at least two hours, and then pre-ran for five minutes at twenty watts. 10nmol of RNA 
sample was mixed with an equal volume of Thermo Fisher loading buffer II composed of 
95% formamide, 18mM EDTA, .025% SDS, small amounts of bromophenol blue, and 
xylene cyanol. Samples were incubated at 95°C for five minutes. Samples were then 
loaded into the gel and ran for six hours at twenty watts with 1x TBE used as running 
buffer. RNA was detected in the gel using short wavelength UV and extracted for gel 
purification. 
 
Gel Purification: RNA samples excised from the gel were mixed with 500ul of 
acrylamide crush and soak buffer (0.5M ammonium acetate, .1%SDS, and .1mM EDTA) 
and pulverized. They were then left to incubate overnight at 4°C. Samples were then run 
through a .22um cellulose acetate centrifuge filter column for 1 minute at 14,000 RPM.  
 
Phenol Chloroform extraction: 500ul of Phenol:Chloroform:isoamyl alchohol (25:24:1) 
was added to the sample, vortexed, and centrifuged for 1 minute at 14,000RPM. The 
bottom layer was removed and discarded. 500ul of chloroform:isoamyl alcohol (24:1) 
was then added to the sample. Samples were once again vortexed and centrifuged for 1 
minute at 14,000RPM. The bottom layer is removed once more and discarded. 
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Ethanol Precipitation: 1500ul of ethanol and 50ul of 3M sodium acetate was mixed 
with the sample. The sample was left at -20°C for 1 hour and centrifuged for 30 minutes 
at 14,000RPM at 4°C. Supernatant was discarded and the sample was washed with 
500ul 70% cold ethanol.  The samples are once again centrifuged at 14,000RPM. 
Supernatant is removed and the samples were left to dry.  
 
Quantification: Samples were then diluted with water until the UV spectrophotometer 
reading A260 was between 0.2 and 0.8. The concentration was then determined using the 
absorbance value and the extinction coefficient of the RNA sample. 
 
P32 5’ end labeling: 2.5pmol of each sample was 5’ labeled with γ32-P. 2.5pmol was 
dried to a solid using a speedvac. A master mix containing 1ul of T4 Polynucleotide 
Kinase buffer, 5.6ul Water, and .4ul of T4 polynucleotide kinase was prepared. 7ul was 
aliquoted into each sample of dried RNA and resuspended. 3ul of [γ32-P] ATP was 
added to each sample and left to incubate at 37°C for one hour. 
 
Spin Column purification: Illustra Micropsin G-25 columns were prepared by 
centrifugation at 735 RCF for one minute. 250ul of water was then added to the columns 
and centrifuged again to remove trace amounts of ethanol. The columns were then 
placed in microcentrifuge tubes that contained 25ul of Thermo Fisher loading buffer II. 
15ul of water was added to each sample and then loaded into the G-25 spin column. 
Columns were then centrifuged at 735 RCF for two minutes. Columns were then 
discarded and the sample was incubated at 95°C for 5 minutes.  
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Repurification: All samples were purified in a denaturing polyacrylamide gel, phenol-
chloroform extracted, and precipitated as described previously. To determine the 
location of the RNAs in the gel use a phosphor screen instead of short wavelength UV. 
 
Native gel and RNA sample preparation: A 4% acrylamide:bisacrylamide 80:1 native 
gel was prepared (27.25ml DEPC treated water, 1.65ml 10xTBE, 3.3mL 40% 
acrylamide, 830ul 2% bisacylamide, 133ul of 10% APS, and 66.6ul of Temed) and left to 
polymerize for at least 2 hours. The RNA samples were then resuspended in 
hybridization buffer (10mM Tris HCl pH7.5, 100mM NaCl, and .1mM EDTA) so that the 
final concentration was 10 times less than the molar concentration of the ELAV protein 
sample. Samples were then incubated at 65°C for 5 minutes. 
 
ELAV-RNA hybridization: A master mix was prepared consisting of 1ul 10x reaction 
buffer (450mM Tris HCl ph 7.5, 5mM NaCl, and 400 mM KCl), 1ul of 250ug/ml tRNA, 1ul 
5mM DTT, 1ul 500ug/ml BSA, and 1ul of 6units/ul RNAse inhibitor.  5ul of the 
hybridization mix was aliquoted per sample and 4.35ul of ELAV protein, or GST buffer 
without protein was added to each tube. Then .65ul (154nM) of RNA sample was added 
to its respective tube. Hybridizaion was allowed to take place for 20 minutes at room 
temperature, and then 3ul of loading buffer was added to each sample. 
 
 
EMSA: The gel was pre-run for 15 minutes at 250V. Samples were then loaded into the 
gel while still running at 250V. The gels were then ran for 2 hours and 20 minutes in a 
cold room at 4°C.  Gels were then dried on a gel dryer at 80°C for 1 hour with vacuum.  
A phosphor screen was exposed to the gel overnight and imaged the following day. 
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Negative Geotaxis assay: 
The negative geotaxis assay performed was adapted from the RING assay[144]. Flies 
were collected flies within 24hr of eclosion and sorted into groups of 10 by gender and 
genotype with minimal use of CO2. Flies were allowed to recover for 18 hours on regular 
food in the incubator. Flies were transferred to the climbing apparatus, which consisted 
of two polystyrene tubes (Genesee Scientific CAT# 32-110) and allowed to acclimate for 
at least 5 minutes. The test was performed by mechanically tapping them down 5 times 
rapidly with consistent force. A picture was taken after 10 seconds to determine how 
many had climbed more than 3cm. Flies were allowed to rest for 1 minute before 4 more 
trials were completed. A total of 5 trials on the same group of flies constituted a N of 1. 
This was performed for a N of 5 for each gender/genotype. 
 
Embryo Collection and Fixation: To analyze the embryonic ventral nerve cord, flies 
with the genotype of interest were placed in cages containing grape agar and thin layer 
of yeast paste to lay eggs. Grape agar plates were made using 350ml ddH20, 120ml 
grape juice, 15g agar gelidium (MOORAGAR CAT# 41054) and 13g of sugar. The mix 
was allowed to boil for 5 min and 2ml of propionic acid (Sigma CAT# 402907) was 
added after the mix had cooled. Grape agar mix was then poured into 60mm petri dishes 
(Genesee Scientific CAT# 32-105). Yeast paste was prepared mixing standard bread 
yeast with water until a peanut butter-like consistency was reached. Changing the plate 
two times after over the course of 24 hours synchronized the embryos on the plates. 
Following synchronization, flies were allowed to lay eggs for 2 hours per plate. Grape 
plates were then allowed to age for ~16 hours to ensure the majority of embryos 
collected are at stage 17 embryos. Approximately 200ul of embryos were collected and 
placed in a sieve and washed 3X with .02% triton-X 100 (Sigma CAT# T8787). Embryos 
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were then dechorionated by incubation for five minutes in a 50% bleach solution and 
then rinsed again 3X with .02% triton-X. Embryos were then transferred to a 1.7ml 
microcentrifuge tube (Genesee Scientific CAT# 22-284) containing equal parts heptane 
(Fisher Scientific CAT# H350) and 4% paraformaldehyde/PBS (Boster CAT# AR1068) 
and allowed to incubate with shaking for 20 minutes. The lower aqueous phase was then 
removes and replaced with an equal volume of methanol (Fisher Scientific CAT# A452). 
Embryos were then shook vigorously for 1 minute to remove vitelline membrane and 
then allowed to settle. The upper phase was then removed and embryos were washed 
3X with methanol. 
 
1D4 (Fasciclin II) Immunostaining:  To inspect the embryonic VNC for defects, stage 
17 Dscam1 dUTR /CyO GFP embryos were stained by 1D4 immunolabeling. 
Approximately 25ul of fixed embryos were washed with a 1XPBS (Fisher Scientific CAT# 
20012027) .1% Triton solution (PT) 3X for five minutes. Embryos were then incubated in 
750ul of PT + 5% normal goat serum (Invitrogen CAT# 31873) for 30 minutes at room 
temperature with rocking. Primary 1D4 anti-Fasciclin II mouse antibody (Developmental 
Studies Hybridoma Bank CAT# AB_528235) was added to achieve a 1:5 dilution. Rabbit 
Anti-GFP antibody (Life Technologies CAT# A11122) was also added at a dilution of 
1:400 in order to screen out heterozygotes. The embryos were incubated overnight at 4 
degrees Celsius with rocking. Embryos were then washed with PT 3X for 5 minutes with 
shaking, followed by another set of 3 washes in PT for 30 minutes each. After washing 
750ul of PT + 5% normal goat serum was added and secondary goat anti-mouse HRP 
antibody (Jackson ImmunoReasearch laboratories CAT# 115-035-003) along with HRP 
Goat-anti rabbit (Jackson ImmunoReasearch laboratories CAT# 111-035-003) were 
added to dilutions of 1:250 and 1:10,000, respectively. Secondary antibodies were 
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incubated for 3 hours with shaking at room temperature. Embryos were then washed 
according the same regimen after primary antibody incubation. Development of embryos 
took place in 1ml of 3,3’-diaminobenzidine (Sigma CAT# D8001) After two minutes of 
embryos equalizing to the solution, 3ul of 30% hydrogen peroxide (Sigma CAT# H1009) 
was added. Development was allowed to take place until the desired color was 
achieved, usually 30 minutes. The development was stopped by rinsing 3X with PT, 
followed by rinsing 3X with PBS. Embryos were then transferred into 70% glycerol for 
clearing. Correctly staged embryos were selected out using a light microscope and the 
VNC was dissected using custom-made tungsten needles. The VNC was mounted on 












Chapter Three: Results 
 Alternative polyadenylation of transcripts is pervasive in many metazoan 
genomes, including Drosophila, mouse, and human [65, 66]. Recent studies provide 
evidence for an enrichment of thousands of genes with extended 3’ UTR isoforms in the 
CNS, and in Drosophila, at least 383 genes have been shown to have extended 3’ UTR 
isoforms exclusively expressed in neural tissues [66]. In hopes of elucidating a broad 
role for these extensions, especially amongst genes involved in axon guidance, we 
chose to study the function of the Dscam1 extended 3’ UTR. Dscam1 is a relatively well-
characterized gene due to being the most extensively alternatively spliced gene known, 
however, specific function of the extended 3’ UTR isoform remains unknown. 
3.1 Regulation of Dscam1 3´ UTR extension by ELAV 
 In Drosophila, ELAV is the most well studied RBP that mediates 3’ UTR 
extension [73, 95]. To determine if Dscam1 extension was regulated by ELAV, we 
analyzed RNA -seq tracks of Schneider 2 cells that were induced to express ELAV. RNA 
seq tracks provide visualization of relative gene expression of a particular genomic 
region by showing the pile-up of individual reads generated from RNA-sequencing. The 
data revealed that extended isoform variants of Dscam1 are upregulated upon ELAV 
overexpression (Figure 4.A). As a positive control we also show 3’ UTR switching of 
ewg, a known target of ELAV (Figure 4.B) [145]. To confirm this, quantitative real-time 
PCR (qRT-PCR) was performed to measure expression of extended Dscam1 3’ UTR 
isoforms in S2 cells transiently transfected with ELAV (Figure 5.A). Expression of the 
extended transcript is detected by a set of primers specific to the extended isoform, 
while another set of universal primers detects all Dscam1 isoforms. The extended 3’ 
UTR expression is shown as a ratio of extended isoform normalized to the housekeeping 
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gene Rpl32. As a positive control, expression of the extended 3’ UTR variant of erect 
wings (ewg) was measured in the same manner. Analysis reveals that ELAV expression 
in S2 cells increases expression of extended Dscam1 4.46 compared to mock 
transfected cells, suggesting Dscam1 is a target of ELAV. 
 The exact mechanism by how ELAV influences 3’ UTR extension is not known; 
however, ELAV has been proposed to compete with cleavage factors binding U-rich 
elements near the proximal poly(A) site. In order to determine if putative ELAV binding 
sites (EBS) are located within the Dscam1 3’ UTR we first established the location of the 
proximal and distal poly(A) sites. Using the integrative genomics viewer, poly(A) sites 
were identified manually by scanning for USEs, DSEs, and most importantly the PAS 
(Figure 6). Consistent with the idea that proximal poly(A) sites tend to be weaker than 
their downstream counterparts, the proximal poly(A) site of Dscam1 does not contain a 
canonical PAS of A[A/U]UAAA . To identify putative EBSs, U-rich regions were scanned 
for in the vicinity of the poly(A) site. A roughly 52 bp long region with a uracil content of 
63.4% was identified near the proximal poly(A) site and we predicted it to be a possible 
EBS. Interestingly, another potential EBS was found immediately downstream of the 
distal poly(A) site, although there is limited evidence showing ELAV binding near distal 
polyadenylation sites in vivo.  
To test if ELAV was capable of binding these sites, we performed an 
electrophoretic mobility shift assay (EMSA) using 32P 5’ radiolabeled RNA probes and 
recombinant purified ELAV (Figure 7.C). The proximal and distal EBS RNA probes 
consisted of the putative EBS sequences identified above, and were 43 and 58 
basepairs long, respectively (Figure 7.B). The addition of purified ELAV with the RNA 
probes resulted in an upward shift of the band for both proximal and distal probes, 
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suggesting RNA-protein complex formation. ELAV has been shown to bind at least one 
of its targets, ewg, as a dodecamer, and we hypothesize the minor band shift seen in 
ELAV positive lanes may be caused by ELAV binding the substrate as a smaller 
multimer. [146]. To control for non-specific binding of ELAV to the probes, two additional 
probes were generated by disrupting U-rich sequence integrity of the test probes via U to 
G substitution. Addition of ELAV to the mutant RNA probes with disrupted U-rich 
stretches did not result in a shift of the major band. This supports the idea that ELAV 
binding is specific to U-rich sequence motifs. Notably, both mutant probes appeared to 
run through the gel at a faster rate than their U-rich counterparts. We believe that this is 
caused by a reduction in secondary structure of the RNA probes as a result of the U to G 
substitutions.  
We have shown that ELAV overexpression is sufficient to cause Dscam1 
extension in S2 cells and that it is capable of binding at least two regions of the Dscam1 
3’ UTR in vitro; however, it is not clear if the two binding sites tested are necessary for 
Dscam1 3’ UTR extension. In order to test this, we created four different luciferase-
Dscam1 3’ UTR fusion reporters using the psicheck-2 vector (Figure 8.A). The luciferase 
reporters either contained the short Dscam1 3’ UTR, the full-length 3’ UTR, or the full-
length 3’ UTR with either the proximal or distal EBS mutated via site-directed 
mutagenesis. With this reporter system we also hoped to determine the effect(s) that the 
extended Dscam1 3’ UTR has on transcript stability and translational control.  
To specifically detect the expression levels of the short and extended reporter 
isoforms, it was necessary to perform a northern blot targeting luciferase because the 
qRT-PCR primers previously used would be incapable of distinguishing between 
endogenous Dscam1 and the reporter construct. The psicheck-2 vector is under the 
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control of the constitutively active SV40 promoter and preliminary experiments showed 
expression of the reporter in transfected S2 cells was below detectable levels for 
northern blot (data not shown). We decided to switch to HeLa cells, a mammalian line, in 
an attempt to improve expression of the reporter. In a preliminary test, HeLa cells were 
transfected with the reporter containing either no 3’ UTR, the Dscam1 short 3’ UTR, or 
the full-length Dscam1 3’ UTR, and a northern blot for luciferase was performed. 
Although HeLa cells yielded high expression of the reporter, multiple splice variants were 
detected which could not be explained (Figure 8.B). This suggests that the Psicheck2 
vector is not appropriate for studying APA of Dscam1, and calls into question its 
suitability as a reporter construct for studies of Drosophila sequences in S2 transfection 
experiments. 
It was our opinion that the simplest solution to this problem was to switch back to 
the S2 cell system with the use of a previously described UAS-driven EGFP reporter 
[131]. Generation of these constructs is currently underway (Figure 9.A). A preliminary 
test transfection of the empty EGFP construct and the EGFP reporter containing the 
short Dscam1 3’ UTR was performed to determine efficacy of the new system. A 
northern blot targeting EGFP was able to detect sufficient levels of the reporter, and 
yielded the expected band sizes suggesting this reporter system is adequate for testing 
the effects the Dscam1 3’ UTRs on transcription.  
3.2 Function of Dscam1 3´ UTR extension 
3.2.1 Generation of the Dscam1 extended 3’ UTR deletion 
 Dscam1 plays several crucial roles during embryonic neural development 
including axon guidance and establishing unique neuron identity. Although many of the 
roles of Dscam1 in development have been well characterized, the role of the extended 
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3’ UTR in these developmental functions remain unknown. In order to directly study the 
biological importance of the Dscam1 extended 3’ UTR in vivo, we utilized the 
CRISPR/CAS9 system to create a mutant fly incapable of making the extended 3’ UTR 
isoform (hereinafter referred to as Dscam1 dUTR mutant).  
 To generate the Dscam1 dUTR mutant, two guide RNAs were designed flanking 
the Dscam1 extended 3’ UTR region for Cas9 mediated cleavage (Figure 10. A). Exactly 
134bp downstream of the Dscam1 proximal cleavage site was left intact to maintain U-
rich DSEs important for proper cleavage of the short 3’ UTR isoform. Following the two 
double-stranded breaks, a 1.8kb RFP cassette containing loxP sites was knocked-in at 
the deletion locus using HDR. The RFP served as a visible marker in order to screen for 
successful deletion mutants. This method generated 3 Dscam1 dUTR lines, A,B, and C. 
To ensure the correct deletion was made, the deletion locus of all three lines was 
verified via Sanger sequencing. Genomic DNA was extracted from five adult flies of each 
line and primers flanking the deletion locus were used for PCR. Sequencing primers 
designed to have coverage through the expected 5’ and 3’ UTR/RFP cassette junction.  
All three lines were confirmed to have an identical deletion on chromosome 2R from 
position 3,204,852 to 3,206,962 as expected (Figure 10.B). In addition to our Sanger 
sequencing, line A was independently sequenced by Well Genetics. All three lines 
appeared to be similar phenotypically, and all experiments hereafter were performed on 
line A. To confirm that Dscam1 dUTR mutants were not generating an artificial long 
transcript induced by the CRISPR deletion, we performed a northern blot targeting 
universal Dscam1 transcript (Figure 10.C). The northern blot resulted in only the short 3’ 




3.2.2 Phenotype analysis of the Dscam1 dUTR mutant 
Dscam1 dUTR homozygous flies were determined to be viable, but adults were 
scarce compared to their CyO balanced counterparts. A longevity assay was performed 
to determine if the deletion had an effect on lifespan (Figure 11.). Adult male flies were 
collected within 8 hours of eclosion and seperated into groups of 10 by genotype into 
vials. The vials contained standard food and all flies were housed at 25°C, 55% relative 
humidity, and a 12 hour light-dark cycle. Strikingly, approximately 50% of Dscam1 dUTR 
homozygotes died by day 14 post-eclosion, significantly more than wild type and 
Dscam1 dUTR heterozygous flies. Upon closer inspection, it was seen that mortality was 
almost exclusively due to homozygotes becoming stuck in the food, potentially indicating 
poor locomotor activity. 
It became apparent that locomotor activity is severely diminished in homozygous 
Dscam1 dUTR flies, which creates a propensity for the flies to “drown” in their food 
following eclosion. To better assess the extent of this locomotor defect, a negative 
geotaxis assay was performed to evaluate the climbing ability of homozygous mutants 
following mechanical stimulation (Figure 12.). Groups of 10 flies at a time, seperated by 
genotype and gender, were transferred to the testing apparatus, which consisted of two 
polystyrene vials taped together. Only ~10% of homozygous flies were able to climb 
more than 3cm within the 10 second testing window following mechanical stimulation, a 
roughly 86% reduction in negative geotactic response.  
We hypothesized these locomotor defects were the result of abherrant axon 
guidance during development. To investigate this possibility we examined the ventral 
nerve cord (VNC) of stage 17 embryos for abnormalities in the longitudinal axon tracts at 
the midline (Figure 13.). Defects of the VNC have been previously characterized in 
Dscam1 null mutants by 1D4 (anti-fasciclin II) immuno-staining [147]. Remarkably, we 
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identified several defects in homozygous Dscam1 dUTR mutants similar in nature to 
Dscam1 null mutants. Although not as severe, evidence of axon kinking, defasciculation, 
and breaks in the outermost fascicles were identified.  
The simplest explanation for the phenotypes displayed was an overall change in 
the amount of Dscam expressed as a result of the deletion. First, we investigated the 
amount of total Dscam1 mRNA being produced via qPCR in adult heads (Figure 14.A). 
Using a “universal” primer that detects both long and short 3’ UTR isoforms of Dscam1, 
we found that the Dscam1 dUTR mutants actually made 1.82 fold more overall transcript 
than wild type flies. This was very interesting, and suggested that a compensatory 
mechanism may exist. We expected to see an increase of Dscam1 protein, but this was 
not the case. Western blot for Dscam protein revealed little to no change in the amount 
of protein expression (Figure 14.B).  
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Chapter Four: Discussion 
We have shown that ELAV is sufficient to cause Dscam1 3’ UTR extension in S2 
cells. Furthermore, we were able to show that ELAV is capable of  binding at least two 
different loci on the Dscam1 3’ UTR immediately downstream of the proximal and distal 
PASs.  
Unfortunately, expression problems with our reporter system have delayed us 
from determining the effects that the different 3’ UTRs of Dscam1 have on reporter 
transcription and translation rates in S2 cells. Once the new GFP-Dscam1 3’ UTR 
constructs are made we will also be able to test which U-rich elements are necessary for 
proper Dscam1 3’ UTR extension with the use of the the mutagenized ELAV binding site 
constructs by coexpressing ELAV. If the proximal mutagenized EBS construct is still 
capable of generating the extended 3’ UTR reporter, it woud suggest another EBS within 
the 3’ UTR may be present. Alternatively, this might also suggest a different RBP is 
capable of causing Dscam1 3’ UTR extension. Elav has two homologs in fly, RBP9, and 
FNE [148]. We have data (not shown) that fne is capable of causing 3’ UTR extension of 
at least 3 genes that are targets of ELAV in S2 cells.  
  Generation of the Dscam1 3’ dUTR mutant was a success and demonstrated 
that the extended Dscam1 3’ UTR serves a functional role. Initially it was dissapointing 
to see that unlike Dscam1 null mutants, which don’t survive into adulthood, our mutants 
appeared to be adult viable, however, the mutant flies recapitulated a resemblence of 
the axong guidance defects seen in the embryonic VNC. Homozygous mutants also 
showed a severe defect in negative geotaxis and overall locomotor activity. This defect 
resulted in a significantly increased mortality rate when compared to wild type flies. 1D4 
immunostaining of the embryonic VNC  revealed that longitudinal axon bundles 
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demonstrated breaking, stalling, and increased waviness, suggesting a disruption of 
proper axon guidance during embryonic development. Recent 1D4 immunostains of the 
adult Dscam1 3’ dUTR mutant brain consistently show a major defect with the ellipsoid 
body, a structure known to be involved in locomotor activity (data not shown). 
Interestingly, this result appears similar to the result from Wang et al., 2002 showing that 
flies expressing a reduced diversity of Dscam1 transcripts have ellipsoid body neurons 
that fail to properly segregate [126]. This data suggests that the extended 3’ UTR has an 
important role in the overall function of Dscam1. 
As an additional measure to confirm the mutant phenotypes identified, a shRNA 
knockdown fly for the extended 3’ UTR of Dscam1 was generated. Although not all 
experiments have yet been replicated with this fly, thus far, it recapitualtes the 
phenotyptypes observed in the Dscam1 3’ dUTR mutants. This information suggests that 
the phenotypes displayed are not due to off-target effects of CRISPR. 
Interestingly, our western blot against Dscam in the dUTR mutant indicated 
almost no change in Dscam1 protein levels. This suggests that the defects seen at the 
embryonic VNC are not simply the result of an effect on gene dosage. Since gene 
dosage was unlikely to be responsible for these axon guidance defects, we chose to 
investigate if the extended 3’ UTR isoform differentially localized subcellularly.  
In a study examining the extended 3’ UTR of brain-derived neurotrophic factor 
(BDNF) in mouse, it was found that the extended 3’ UTR isoform of BDNF was 
necessary to target BDNF transcripts dendrites [87]. This was shown by generating 
mutant mice expressing a truncated version of the extended 3’ UTR of the BDNF 
transcript. These mutant mice were unable to target BDNF to apical dendrites which 
reduced the overall amount of BDNF protein found in dendritic spines. The loss of BDNF 
in these spines was shown to cause abnormal development of CA1 pyramidal distal 
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dendritic spines. The targeting of BDNF to dendrites is thought to allow localized 
translation and differential regulation BDNF subcellularly. In a similar study in fly, it was 
shown the the extended 3’ UTR of another gene, calcium/calmodulon-dependent protein 
kinase II (CaMKII) is necessary to maintain the correct basal activity of miniature 
excitatory junctional potentials in the larval neuromuscular junction. While it was shown 
that the extended 3’ UTR of CamKII was not essential for dendritic localization, it was 
shown to be required fo translation-dependent plasticity of spontaneous release [149]. 
To determine if the extended 3’ UTR of Dscam1 was differentially localizing subcellularly 
to neurites, we performed in situ hybridization in wild type flies (data not shown) to 
specifically detect the extended 3’ UTR isoform, however, we were unable to find any 
evidence of this occuring. 
Our latest hypothesis is that the extended 3’ UTR may be associated with 
specific alternatively spliced versions of Dscam1. As mentioned in the introduction, 
certain RNA-RNA interactions have been shown to be involved in splice choice of 
alternative exons in the 3, 6, and 9 exon regions. It could be that secondary structure in 
the extended 3’ UTR participates in these types of interactions to influence upstream 
splicing of exons. To investigate this, we plan to utilize long-read RNA sequencing with 
the new nanopore technology. Current limitations of RNA-seq stem from read-lengths 
which are often too short to cover multiple exon junctions. Oxford Nanopore allows 
sequencing of single-stranded pieces of cDNA that is multiple kilobases long [150]. It is 
the same technology that was utilized to uniquely identify more than 7,800 transcript 
variants of Dscam1 [113]. If we are able to identify a biased usage of alternatively 
spliced exons of associated with the exteneded Dscam1 3’ UTR isoform, we may be 
able to uncover yet another role of the 3’ UTR.  
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Although major defects are observed in the Dscam1 3’-dUTR mutants, the 
mechanism remains unclear. Elucidating the mechanisms responible for the observed 
defects may provide insight into extended 3’ UTR function of other axon guidance genes 













Figure 1. Cleavage machinery and polyadenylation site sequence motifs  
The CTD of RNA Pol II along with symplekin provide the scaffold for many of the 
cleavage factors responsible for 3’ end processing. Upstream elements such as 
UGUA are recognized by Cleavage Factor I, while downstream elements are 
recognized by CstF. The primary sequence motif of the Poly(A) site is the 
hexameric PAS A(A/U)UAAA, which is recognized by CPSF. The CPSF73 subunit 
possesses RNA endonuclease activity that allows for cleavage of the 3’ end, often 
at a CA dinucleotide downstream of the PAS. Following cleavage, PolyA 
polymerase initiates formation of the Poly(A) tail at the site of cleavage.  
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Figure 2. Usage of alternative PAS leads to transcripts with alternative 3’ UTR.  
Cleavage and polyadenylation occurring at the proximal PAS yields a shorter 3’ UTR 
Isoform,	  while	  cleavage	  at	  the	  distal	  PAS	  generates	  the	  longer	  3’	  UTR	  isoform.	  Longer	  
3’	  UTRs	  can	  harbor	  additional	  regulatory	  motifs,	  altering	  gene	  expression	  while	  not	  
affecting	  the	  protein	  coding	  region.	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Figure 3. Dscam1 gene structure and protein function. Dscam1 is the most alternatively 
spliced gene known, able to generate up to 152,064 protein isoforms and 304,128 unique 
mRNA isoforms assuming all combinations are possible. This diversity primarily stems from 
the 3 hypervariable exon clusters 4, 6, and 9, which encode a part or an entire 
immunoglobulin domain. Dscam1 functions as a receptor protein on the surface of neurons. 
It is capable of homophilic binding, leading to neural self-avoidance, or heterophilic binding, 
which provide attractive queues during neural development. 
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Figure 4: ELAV regulates 3´ UTR extensions of neural genes.  
A) RNA-seq data of S2 cells overexpressing ELAV shows an increase in the 
usage of the longer 3’ UTR isoform of Dscam1. B) Ewg, a gene known to be 
under the control of ELAV, is shown to switch to usage of the more distal 3’ UTR 
isoform. EWG undergoes a slightly different version of 3’ UTR APA where in 
addition to 3’ UTR switching, an alternative last terminal exon used. Black 






Figure 5. Overexpression of ELAV in S2 cells influences APA.  
A) qPCR reavels S2 cells overexpressing ELAV show an 4.46 fold increase of Dscam1 
extended 3’ UTR usage. B) Similarly, our positive control, EWG, exhibits a 17.42 fold 
increase in usage of the alternative distal 3’ UTR. In both analysis, fold change of the 
alternative 3’ UTR is normalized to the housekeeping gene Rpl32. 
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Figure 6. Poly(A) sequence motifs identified at the proximal and distal  
Dscam1 3’ UTR cleavage sites. The proximal Dscam1 3’ UTR does not contain a 
canonical PAS, but we identified two potential non-canonical signals just upstream 
of the expected cleavage site. Immediately downstream, two U-rich elements were 
identified as possible ELAV binding sites. The more proximal element was used as 
the proximal ELAV binding site probe for the EMSA. The extended 3’ UTR 
contained 3 overlapping PAS and following the expected cleavage site was a long 
U-rich sequence. This U-rich sequence was used as the distal ELAV binding site 














Figure 7. ELAV binds the Dscam1 3’ UTR. A) Schematic showing the general 
locations of the proximal and distal ELAV probes used in electrophoretic mobility shift 
assays (EMSA) the relative to the predicted PolyA sites. B) U-rich RNA probes used 
to determine ELAV binding capability. To control for non-specific binding, an 
additional set of probes were generated by disrupting the integrity of U-rich stretches 
via U to G mutation (indicated in red text). C) EMSAs revealed that upon the addition 
of recombinant purified ELAV, both proximal and distal radiolabeled probes showed a 
shift upwards, indicating ELAV had bound the probes. Because ELAV binds as a 
dodecamer, the partial shift may be explained as the binding of ELAV in a smaller 
multimeric complex. Both mutated probes were incapable of ELAV binding, evident 
by the lack of shift. 
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Figure 8. Schematic of Luciferase-Dscam1 3’ UTR Constructs. 
A) Dscam1 3’ UTR was fused to luciferase in the psicheck-2 vector. By using this 
reporter system in HeLa cells, we would be able to determine the relative levels of 
each isoform present via northern blot. Performing a luciferase assay would allow 
us to determine the amount of luciferase protein made and correlate translation 
rates to how much of a particular 3’ UTR isoform was present. B) Preliminary data 
showed that expression of the luciferase reporter system produced bands of the 
expected sizes (arrows), but also yielded extra bands with sizes that could not be 
explained.  






Figure 9. Schematic of GFP-Dscam1 3’ UTR constructs.  
A) Proposed design of Dscam1 3’ UTR sequence fused with eGFP in a pUAST vector. A 
second  set of constructs are planned to be made by disrupting U-rich regions within the 
predicted proximal and distal ELAV binding sites via U to C site-directed mutagenesis. 
We hypothesize that disruption of ELAV binding sites may prevent the extended isoform 
from being made, or destabilize the transcript. B) Preliminary northern blot data shows 

















Figure 10. CRISPR/CAS9 deletion strategy and deletion validation.  
A) Guide RNAs were designed flanking the extended Dscam1 3’ UTR region. 
Following deletion, a RFP cassette was knocked-in via homology directed repair 
for use as a visible marker. B) Gene models for the long and short Dscam1 3’ 
UTR isoforms. All 3 homozygous Dscam1-dUTR mutant lines generated were 
verified by Sanger sequencing and produced identical deletions. C) Northern 
blot for universal Dscam1 transcript in adult head shows that Dscam1 dUTR 
homozygotes do not express the long extended isoform (arrow). GAPDH2 used 





Figure 11. Survivorship of Dscam1-dUTR homozygous mutants. Dscam1-dUTR 
mutants showed a severe increase in mortality compared to wild type and balanced 
lines. Curves represent pooled data from independent experiments, with a total N= 5 





Figure 12. Negative geotactic response is impaired in Dscam1-dUTR flies.  
The data shows a ~86.67% reduction in the ability of Dscam1-dUTR(-/-) flies to 
vertically climb 3cm within the 10 second testing period following mechanical 
stimulation compared to wild type flies. Each genotype/sex represents pooled data from 
2-4 independent experiments where each experiment consisted of a group of 10 flies 
undergoing 5 repeated trials.  There was no significant difference detected between 
sexes. A Post hoc comparison using the Tukey HSD test indicated a significant 
difference between the Dscam1-dUTR homozygotes and all other genotypes/sexes 
with a p <.001. 
	  
55 
Figure 13. Dscam1-dUTR mutants show defects at the ventral nerve cord.  
A) Wild type ventral nerve cord at embryonic stage 17. B) Dscam1 null ventral nerve 
cord shows increased waviness of the longitudinals and severe breaks of the outermost 
fascicles (arrows). C) Dscam1 extended 3’ UTR mutants also displays increased 
waviness of the longitudinals as well as defasciculation (arrowhead) and some breaks 
of the outermost fascicles. Images taken by Dr. Thomas Kidd. 
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Figure 14. Dscam1-dUTR mutants exhibit increased expression of Dscam1 
mRNA, but no change in protein expression. 
A) Schematic showing qPCR primers that detect both extended and short 3’ UTR 
isoforms of Dscam1. qPCR indicates a 1.82 fold increase of overall Dscam1 transcript 
being produced in the Dscam1-dUTR mutant compared to wild type in adult head.      
B) Western blot analysis of adult head tissues shows almost no change in protein levels 





I. Plasmid Construct List 
 
Construct Name Backbone Inserted Sequence Restriction Sites 
Used
pDest60-ELAV pDest60 ELAV Coding Region gateway
Psicheck2-Dscam1 Short Hong Psicheck-2 Short Dscam1 3' UTR NotI, XhoI
Psicheck2-Dscam1 Long Hong Psicheck-2 Extended Dscam1 3' UTR NotI, XhoI
GFP-Dscam1 Short pUASTattb eGFP Short Dscam1 3' UTR XhoI, XbaI
GFP-Dscam1 Long pUASTattb eGFP Extended Dscam1 3' UTR XhoI, XbaI
GFP-Dscam1 Long-prox mut pUASTattb eGFP Extended Dscam1 3' UTR w/ mutated 
proximal ELAV binding site
XhoI, XbaI
GFP-Dscam1 Long-distal mut pUASTattb eGFP Extended Dscam1 3' UTR w/ mutated 








rp20_DscamUni_CLN1 GATCGCGGCCGCTAATTTGTAAGCGCCCTCTGCG Amplify Dscam1!short!3'!UTR
rp21_DscamShort_CLN2 GATCCTCGAGTGGTGGTGTCTCCACAGATTTC
rp20_DscamUni_CLN1 GATCGCGGCCGCTAATTTGTAAGCGCCCTCTGCG Amplify Dscam1!Extended!3'!UTR
rp22_DscamLong_Cln3 GATCCTCGAGACCGGAATTGACTGAACGATTC
ELAV_Forward CACCGACTTTATTATGGCAAATACCGGA Amplify ELAV for Protein Expression
ELAV_Reverse CTTGGCTTTGTTGGTCTTGAAGCT
Dscam_prox_elav site3 caaaacaataatcaaacaaaagcgaacgtaatcaatttaaaatgagatcgagatcatatatttagcaacttatgaactaataacttaggatagat Mutagenesis Primers for 1st half of proximal ELAV binding site
Dscam_prox_elav site4 atctatcctaagttattagttcataagttgctaaatatatgatctcgatctcattttaaattgattacgttcgcttttgtttgattattgttttg
Dscam_prox_elav_site5 aataatcaaacaaaagcgaacgtaatcagtttgagatgagatcgagatcatatatttagcaacttatg Mutagenesis Primers for 2nd half of proximal ELAV binding site
Dscam_prox_elav_site6 cataagttgctaaatatatgatctcgatctcatctcaaactgattacgttcgcttttgtttgattatt
Dscam_ELAV_Dist_mut1 gactgaacgattccttttgaatcagagatagataggatggatattgtgaccgccagttaaaaaaagcaaatgaaattaaacagggc Mutagenesis Primers for 1st half of distall ELAV binding site
Dscam_ELAV_Dist_mut2 gccctgtttaatttcatttgctttttttaactggcggtcacaatatccatcctatctatctctgattcaaaaggaatcgttcagtc
Dscam_ELAV_Dist_mut3 atagataggatggatattgtgaccgccagttagagagagcagatgagattagacagggcatttggttttatccaacataaattg Mutagenesis Primers for 2nd half of distal ELAV binding site
Dscam_ELAV_Dist_mut4 caatttatgttggataaaaccaaatgccctgtctaatctcatctgctctctctaactggcggtcacaatatccatcctatctat
Proximal Dscam1'EMSA!RNA!probe UUUUUAAUUGAUUACGUUCGCUUUUGUUUGAUUAUUGUUUUGG Proximal RNA probe to test ELAV binding in EMSA
Proximal Dscam1!mutated!EMSA!RNA!Probe UGUGUAAGUGAGUACGGUCGCUGUGGUGUGAUGAUGGGUGUGG Proximal U to G mutated RNA probe to test ELAV binding in EMSA
Distal Dscam1'EMSA!RNA!probe UGUUUAAUUUCAUUUGCUUUUUUUAACUGGCGGUUACAAUAUUCAUUCUAUUUAUUUU Distal RNA probe to test ELAV binding in EMSA
Distal Dscam1 !mutated!EMSA!RNA!Probe UGUGUAAUGUCAUGUGCUGUGUGUAACUGGCGGUGACAAUAUGCAUGCUAUGUAUGUG  Distal U to G mutated RNA probe to test ELAV binding in EMSA
rp_qf_67_DscamUni2_Left TCCGGAGTACAGGCTACCG qPCR primer set to detect universal Dscam1 !transcript
rp_qf_68_DscamUni2_Right GGACAGTCCTCAATCTACACG
rp_qf_6_dscam_ex3UTR GCGTTTTAAACTGCCTGTCC qPCR primer set to detect extended Dscam1'3''UTR!transcript
rp_qf_7_dscam_ex3UTR CAACTTCAACGCACATCAGG
rp_NF_1_DscamUni GGTCTTGATCACTCCGTTGG Used to make Dscam1'Universal!Northern!Probe
rp_NF_2_DscamUni CACCTACAACATTCGCATCG
N.f.709_GAPDH2 GGCATCCACTCACTTGAAGG Used to make'GAPDH2'Northern!Probe
N.f.710_GAPDH2 TCAGCTTCACGAACTTGTCG
R.Luc probe Forward TGATCGGAATGGGTAAGTCC Used to make Luciferase Northern Probe
R.Luc probe Reverse GCTATTGTCGAGGGAGCTAA
rp_N_1_GFP TAAACGGCCACAAGTTCAGC Used to make eGFP Northern Probe
rp_N_2_GFP CTTGTACAGCTCGTCCATGC
Proximal Dscam1'EMSA!RNA!probe UUUUUAAUUGAUUACGUUCGCUUUUGUUUGAUUAUUGUUUUGG Proximal RNA probe to test ELAV binding in EMSA
Proximal Dscam1!mutated!EMSA!RNA!Probe UGUGUAAGUGAGUACGGUCGCUGUGGUGUGAUGAUGGGUGUGG Proximal U to G mutated RNA probe to test ELAV binding in EMSA
Distal Dscam1'EMSA!RNA!probe UGUUUAAUUUCAUUUGCUUUUUUUAACUGGCGGUUACAAUAUUCAUUCUAUUUAUUUU Distal RNA probe to test ELAV binding in EMSA
Distal Dscam1 !mutated!EMSA!RNA!Probe UGUGUAAUGUCAUGUGCUGUGUGUAACUGGCGGUGACAAUAUGCAUGCUAUGUAUGUG  Distal U to G mutated RNA probe to test ELAV binding in EMSA
Dscam_deletion_Seq1 AATGAGCCGCAATTAGTTGA Sequencing primers for Dscam1'dUTR!ends
Dscam_deletion_Seq2 GAACATGAGTTATACGCATT






III. Dscam1 3’ UTR Sequence 
chr2R:3,204,518 - 3,208,190 
 
                    20                   40                  60 
  TAATTTGTAAGCGCCCTCTGCGGCGGTGGG CGTGGCATTTTAGCTTAGTGTTTTAGGTGC 
  ATTAAACATTCGCGGGAGACGCCGCCACCC GCACCGTAAAATCGAATCACAAAATCCACG 
 
                    80                  100                 120 
  ATGAAGTGCGTGGGAGTTGAATGACACTTA GAGACACAGGACACAGATACACACAGACAG 
  TACTTCACGCACCCTCAACTTACTGTGAAT CTCTGTGTCCTGTGTCTATGTGTGTCTGTC 
 
                   140                  160                 180 
  ATCATCAGGACACAAGGAAAGAGATAGAGA AAGAGAGGGAGTTATATACCGAATATACAC 
  TAGTAGTCCTGTGTTCCTTTCTCTATCTCT TTCTCTCCCTCAATATATGGCTTATATGTG 
 
                   200                  220                 240 
  GTAAAATATTCAACTACTTCGAGTAATTAT AGCGAAGGAATGCAAGTTTCAAGAAACATA 
  CATTTTATAAGTTGATGAAGCTCATTAATA TCGCTTCCTTACGTTCAAAGTTCTTTGTAT 
 
                   260                  280                 300 
  TTTATATTGTCTATGCAAGCAGCAAACCAA ACTTACATAAAGTATATAAGTACATTCAAT 
  AAATATAACAGATACGTTCGTCGTTTGGTT TGAATGTATTTCATATATTCATGTAAGTTA 
 
                   320                  340                 360 
  GGATAACTACTATAAGAGAGTGCTGGAGAC ACTGAAGGAAATTACTCAAGTTATTCGAGA 
  CCTATTGATGATATTCTCTCACGACCTCTG TGACTTCCTTTAATGAGTTCAATAAGCTCT 
 
                   380                  400                 420 
  GGAACAGAAAACGAAATCTCAAGATCAAGA TCATACTTACGTATTCGAACTAATTTTCAA 
  CCTTGTCTTTTGCTTTAGAGTTCTAGTTCT AGTATGAATGCATAAGCTTGATTAAAAGTT 
 
                   440                  460                 480 
  TAATGTACTTTAGTTTTAAGCGGTGTCTAC CGAAATATCAGAGCAACAGCAACTGAGATG 
  ATTACATGAAATCAAAATTCGCCACAGATG GCTTTATAGTCTCGTTGTCGTTGACTCTAC 
 
                   500                  520                 540 
  GATTCTTGTGTGTAAGAGGAGATGATTCGA AATCTGTTTGTGTAAACTTTTGCCATCTAT 
  CTAAGAACACACATTCTCCTCTACTAAGCT TTAGACAAACACATTTGAAAACGGTAGATA 
 
                   560                  580                 600 
  GCCAGGAGCAGAAAACTCATCCTTTGCCTA GCCTAAGTCAAAGTCATAATATTAACTCGT 
  CGGTCCTCGTCTTTTGAGTAGGAAACGGAT CGGATTCAGTTTCAGTATTATAATTGAGCA 
 
                   620                  640                 660 
  CTAATTGATATATTTAGTCGTAACATATGC GTAATATGTATGATTTCTTCCTATGCATTT 




                     680                  700                 720   TATAATTCGTATGGACAGCGCACATTTGGA GTTTTGTTTGCGTTTTGCGTTGACTTGTGA 
  ATATTAAGCATACCTGTCGCGTGTAAACCT CAAAACAAACGCAAAACGCAACTGAACACT 
 
                   740                  760                 780 
  TGATTGTTAATTTACAGAGCTTTGTGAGTG AGTACTTACGATTGTGCTCATTACTCGCTT 
  ACTAACAATTAAATGTCTCGAAACACTCAC TCATGAATGCTAACACGAGTAATGAGCGAA 
 
                   800                  820                 840 
  TGTTCTTTATTTACAGACAAGTGATTGTCC TATCTTAGTTCGCCCTTATTTTTAATTCAA 
  ACAAGAAATAAATGTCTGTTCACTAACAGG ATAGAATCAAGCGGGAATAAAAATTAAGTT 
 
                   860                  880                 900 
  AAATGCGCTTCCAACAGAACAAATCGAAAC TGTTCAATGCACAAATCGCAGCCACAACAA 
  TTTACGCGAAGGTTGTCTTGTTTAGCTTTG ACAAGTTACGTGTTTAGCGTCGGTGTTGTT 
 
                   920                  940                 960 
  TTGAATGTATTATACAAGATCCCCAGGACA CCGAAAAACCAAAACCCCTAACCCGAAACA 
  AACTTACATAATATGTTCTAGGGGTCCTGT GGCTTTTTGGTTTTGGGGATTGGGCTTTGT 
 
                   980                 1000                1020 
  CAGATACACTCAAGCACGATTTATTAAACC AATTCTGATATAGACCGTTCTGAACATGAG 
  GTCTATGTGAGTTCGTGCTAAATAATTTGG TTAAGACTATATCTGGCAAGACTTGTACTC 
 
                  1040                 1060                1080 
  TTATACGCATTTGAAGCTTTAAGAGAACCT GAAATTGTTTATTTCACTTCATTTGATCTA 
  AATATGCGTAAACTTCGAAATTCTCTTGGA CTTTAACAAATAAAGTGAAGTAAACTAGAT 
        Possible PolyA Sginal      Prox ELAV binding site 
                  1100                 1120                1140 
  TCCTAAGTTATTAGTTCATAAGTTGCTAAA TATATGATTTTGATTTTATTTTTAATTGAT 
  AGGATTCAATAATCAAGTATTCAACGATTT ATATACTAAAACTAAAATAAAAATTAACTA 
       U-Rich element          Proximal Cleavage Site       
                  1160                 1180                1200 
  TACGTTCGCTTTTGTTTGATTATTGTTTTG GGGTTCCGCCCATTGCGGCCAGAAATCTGT 
  ATGCAAGCGAAAACAAACTAATAACAAAAC CCCAAGGCGGGTAACGCCGGTCTTTAGACA 
 
                  1220                 1240                1260 
  GGAGACACCACCAACACTTCAAAGACTGAC TAATGCAAGCTAAAAACGAAGCCGGATCAA 
  CCTCTGTGGTGGTTGTGAAGTTTCTGACTG ATTACGTTCGATTTTTGCTTCGGCCTAGTT 
 
                  1280                 1300                1320 
  TCCAAGTTTTGCGGGATGAAACCGATGCAA TGGAGCTACAGAATATCCAGTATTTTGCTC 
  AGGTTCAAAACGCCCTACTTTGGCTACGTT ACCTCGATGTCTTATAGGTCATAAAACGAG 
 
                  1340                 1360                1380 
  AACACGTAGAATAGCAGGGCATTTCCGGGT GAATCAACTGCCATAAGATCGGAACTGGAT 
  TTGTGCATCTTATCGTCCCGTAAAGGCCCA CTTAGTTGACGGTATTCTAGCCTTGACCTA 
61 
                   1400                 1420               1440 
  TTTGATCCTCGTCCCTTAAGCACATCACGA ACTGCATTTATCCAATGGGAGATTTATTGT 
  AAACTAGGAGCAGGGAATTCGTGTAGTGCT TGACGTAAATAGGTTACCCTCTAAATAACA 
 
                  1460                 1480                1500 
  CAGGTTTATCAGGCGTTTAGTTTCACTTCA ATCTTCTTCTCCTTAAGTTCCCACTTAACC 
  GTCCAAATAGTCCGCAAATCAAAGTGAAGT TAGAAGAAGAGGAATTCAAGGGTGAATTGG 
 
                  1520                 1540                1560 
  TATCCGAACTAATACTCACTCTTACCCAGA CTATACCAGTTTTATATAGATATATACGTA 
  ATAGGCTTGATTATGAGTGAGAATGGGTCT GATATGGTCAAAATATATCTATATATGCAT 
 
                  1580                 1600                1620 
  TATAAATATATAAATGTAGTGTTGTGAAAA AATAAGATTGCTTACCTATATGAGTGTACT 
  ATATTTATATATTTACATCACAACACTTTT TTATTCTAACGAATGGATATACTCACATGA 
 
                  1640                 1660                1680 
  ACAAATTTTCATGGCAAACGAACTACAAAT ATTAAGTAGTGTATAGTAAAGGAAATGGCA 
  TGTTTAAAAGTACCGTTTGCTTGATGTTTA TAATTCATCACATATCATTTCCTTTACCGT 
 
                  1700                 1720                1740 
  TTTAATCAATAAGCAAACGAAAGGAATACA TCTACAAATTTTCAAGTAATTAAAATAGCA 
  AAATTAGTTATTCGTTTGCTTTCCTTATGT AGATGTTTAAAAGTTCATTAATTTTATCGT 
 
                  1760                 1780                1800 
  AGCAATATTCTAGAGTCAAAAGAACGTTGG ATTTCACAAATTGTAACGAACAAACACGAT 
  TCGTTATAAGATCTCAGTTTTCTTGCAACC TAAAGTGTTTAACATTGCTTGTTTGTGCTA 
 
                  1820                 1840                1860 
  TTTAATTACACTCGTAAAATTTATAAACTT TTCGGCAAATCAAAATCAAAACAAAAACTT 
  AAATTAATGTGAGCATTTTAAATATTTGAA AAGCCGTTTAGTTTTAGTTTTGTTTTTGAA 
 
                  1880                 1900                1920 
  TTGGCATTAAAAAGAAAAAGAAAACGAAAA CAAAAACATAAACAAAGCGGTTTGAAGAAG 
  AACCGTAATTTTTCTTTTTCTTTTGCTTTT GTTTTTGTATTTGTTTCGCCAAACTTCTTC 
 
                  1940                 1960                1980 
  AAAACACTTAGGCTAAGTACGCTAATATAA CATAATCCATTTTTCATACTATATATCATG 
  TTTTGTGAATCCGATTCATGCGATTATATT GTATTAGGTAAAAAGTATGATATATAGTAC 
 
                  2000                 2020                2040 
  CATGAATAATGTATACTCGTAATTCGAATC AATCCGAGTCGGATGCTTTTTGAGTTGCTT 
  GTACTTATTACATATGAGCATTAAGCTTAG TTAGGCTCAGCCTACGAAAAACTCAACGAA 
 
                  2060                 2080                2100 
  CATTGTCAAAAGGAATATGGCGAAATTAAC GTTTTGAATTCATTAGACGCGCTTCATACT 
  GTAACAGTTTTCCTTATACCGCTTTAATTG CAAAACTTAAGTAATCTGCGCGAAGTATGA 
62 
 
                  2120                 2140                2160 
  TGTAATTATTTAAGCGATAAGCGTACATGC ATATACAAACATATACAGATAATTTTTTAC 
  ACATTAATAAATTCGCTATTCGCATGTACG TATATGTTTGTATATGTCTATTAAAAAATG 
 
                  2180                 2200                2220 
  TTAACTTTACATAAAACGCATTAATCAAAA TTCAACTCCCAAGAAACATTAACCAGAAGG 
  AATTGAAATGTATTTTGCGTAATTAGTTTT AAGTTGAGGGTTCTTTGTAATTGGTCTTCC 
 
                  2240                 2260                2280 
  TCAGACACAAAATCCAAGACACTCTCACAC GAAGGACATTCAACTTCAACGCACATCAGG 
  AGTCTGTGTTTTAGGTTCTGTGAGAGTGTG CTTCCTGTAAGTTGAAGTTGCGTGTAGTCC 
 
                  2300                 2320                2340 
  CTCGACATCGAGGATAACTAAGCACGATCA GCACACATTTGAATTCTGTAACCAGGCGGA 
  GAGCTGTAGCTCCTATTGATTCGTGCTAGT CGTGTGTAAACTTAAGACATTGGTCCGCCT 
 
                  2360                 2380                2400 
  CAGGCAGTTTAAAACGCATTTATACTAATC ACTCGCTCCTTCTTAGCAGAACGAATATTA 
  GTCCGTCAAATTTTGCGTAAATATGATTAG TGAGCGAGGAAGAATCGTCTTGCTTATAAT 
 
                  2420                 2440                2460 
  TATGAAATTAAGAGAGAATCAATACCCCAG TGGAAACATTCGTAATCATTAAGCGCGGCA 
  ATACTTTAATTCTCTCTTAGTTATGGGGTC ACCTTTGTAAGCATTAGTAATTCGCGCCGT 
 
                  2480                 2500                2520 
  TATACGGTAAACCCCAAATTGAATACTACA AATATGTGTATTACTAATTACATTTACGAA 
  ATATGCCATTTGGGGTTTAACTTATGATGT TTATACACATAATGATTAATGTAAATGCTT 
 
                  2540                 2560                2580 
  AGCATACATATATTAACTATATTAAATATT GAATGTATTGAATTGACAACAGTCGGCATG 
  TCGTATGTATATAATTGATATAATTTATAA CTTACATAACTTAACTGTTGTCAGCCGTAC 
 
                  2600                 2620                2640 
  CTGGGGATTCACTATCCTGAACCGCTTCAC GTGGAACGGATTGGTAATCCCGCCCCAAAC 
  GACCCCTAAGTGATAGGACTTGGCGAAGTG CACCTTGCCTAACCATTAGGGCGGGGTTTG 
 
                  2660                 2680                2700 
  TCGATCACTTTGCATGTCCGACCAGCGAAG AAAGAATTTGTCAGTTTCCAGTTTCAGTGT 
  AGCTAGTGAAACGTACAGGCTGGTCGCTTC TTTCTTAAACAGTCAAAGGTCAAAGTCACA 
    Distal PolyA Signals 
                  2720                 2740                2760 
  CATAAAAGTCAAACAGAAACCAATTAAAAT TAAATAAATGCCAATTTATGTTGGATAAAA 
  GTATTTTCAGTTTGTCTTTGGTTAATTTTA ATTTATTTACGGTTAAATACAACCTATTTT 
                         
                  2780                 2800                2820 
  CCAAATGCCCTGTTTAATTTCATTTGCTTT TTTTAACTGGCGGTTACAATATTCATTCTA 
  GGTTTACGGGACAAATTAAAGTAAACGAAA AAAATTGACCGCCAATGTTATAAGTAAGAT 
 Distal Cleavage Site    Distal ELAV Binding Site 
                  2840                 2860 
  TTTATTTTGGATTCAAAAGGAATCGTTCAG TCAATTCCGGT 
  AAATAAAACCTAAGTTTTCCTTAGCAAGTC AGTTAAGGCCA 
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